or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 87 pharmaceutical analysis PhD Projects, Programmes & Scholarships for Self-funded Students
pharmaceutical analysis PhD Projects, Programmes & Scholarships for Self-funded Students
We have 87 pharmaceutical analysis PhD Projects, Programmes & Scholarships for Self-funded Students
Analysis of Magnetically Susceptible Nanoparticles via confocal and fluorescence spectroscopy
Research Group:
Chemistry and Biosciences
A project is requested for a student to design a device capable of studying medically targeted nanoparticles (with potential applications in cancer therapy) under both microscopic and fluorescence devices. Read more
Last chance to apply
Universal electrometric detector for HPLC eluent analysis
Applications are invited for a 4 year PhD studentship starting in Autumn 2025 as part of the EPSRC CDT in Aerosol Science. Project description. Read more
Synthesis of Microcarriers for Focal Drug Delivery to the Brain
For neurodegenerative diseases, where a specific cell type is lost, it is possible to consider replacing these cells to restore the lost function. Read more
Representative Electron Microscopy through Limiting Damage
Research Group:
School of Chemical and Process Engineering
Electron microscopy is used in the examination of a broad range of materials, allowing important determination of structure-property relationships. Read more
EastBio - Organic Synthesis and Evaluation of Antibiotic Derivatives for the Disruption of Ribosomal Translation
This project will focus on the organic synthesis and biological screening of novel natural antibiotic derivatives that disrupt mRNA translation by ribosomes in diverse model organisms. Read more
Sustainable synthesis: reaction development and applications in synthesis
A PhD position is available in the group of Professor John Bower at the University of Liverpool (https://bowerresearchgroup.wordpress.com/). Read more
Elucidating novel anti-cancer drug responses in advanced ovarian cancer
Ovarian cancer is one of the most lethal gynaecological malignancies, often diagnosed at advanced stages due to non-specific symptoms and a lack of early detection methods. Read more
How should the environmental impact of medicines be considered in the context of trial outcomes?
Background. Non-inferiority trials are designed to show that a new treatment is “not worse than” an active control by more than a pre-specified margin. Read more
Targeting acute inflammation to reduce coronary artery vein graft failure using bioengineering
The long saphenous vein (LSV) is the most commonly used conduit in cardiac surgery to treat patients with coronary artery disease; however, its use is complicated by high failure rates due to the development of vascular inflammation, intimal hyperplasia (IH) and accelerated atherosclerosis. Read more
Development and Characterization of Hydrogel-Based Model(s) for Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma (PDAC), which develops from cells lining pancreas ducts, represents 95% of all pancreatic cancer cases. Read more
Bioinspired Nanomaterials Based Miniaturised Soft Robots for High Precision Regiospecific Drug Delivery to Malignant Tumours
Cancer is one of the top global public health challenges, estimated to have caused 10M deaths (2020) according to WHO. Throughout the years, standardised therapeutic protocols have been developed and evolved for the treatment of various types of cancers. Read more
Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
Research Group:
Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs). Read more
Improving the regenerative capacity of Junctional Epidermolysis Bullosa skin by re-activating YAP/TAZ signalling.
This is an exciting opportunity for a 4-year DEBRA UK-funded PhD studentship within the Institute of Dentistry of Barts and The London Medical School and Dentistry at Queen Mary University of London (QMUL). Read more
Development of a Dual Nanogel for Junctional Epidermolysis Bullosa
Junctional Epidermolysis Bullosa (JEB) is a debilitating disease where a weak interface between the dermis and epidermis leaves the skin prone to delamination and blistering. Read more
Development of anti-inflammatory-based nanoparticles for topical treatment of psoriasis
Psoriasis remains one of the most common forms of skin related autoimmune diseases with more than 4% of prevalence in the developed world. Read more